America June 24, 2024
Cooley-Led Therapy Developer Alumis Aims For $300M IPO
Venture-backed drug developer Alumis Inc. launched plans on Monday for an estimated $300 million initial public offering, guided by Cooley…
America June 24, 2024
Venture-backed drug developer Alumis Inc. launched plans on Monday for an estimated $300 million initial public offering, guided by Cooley…
By Rihem Akkouche
America June 14, 2024
Australian biotechnology firm Telix Pharmaceuticals Ltd., whose U.S. shares were set to debut trading on Friday, canceled plans for an…
By Rihem Akkouche
America April 16, 2024
Venture-backed data security firm Rubrik Inc. has announced plans for a $679 million initial public offering, seeking to ride the…
By Rihem Akkouche
And More February 23, 2024
Founded in 2005, Reddit is a highly popular social network where people share news, updates, ideas, and thoughts about diverse…
By Gabrielle Seunagal
America November 3, 2023
In a heart-pounding financial feat, Lexeo Therapeutics Inc., a trailblazing gene-therapy focused biotechnology firm, has unleashed a torrent of excitement…
By Rihem Akkouche
America September 5, 2022
Volkswagen on Monday announced its plans to float the sportscar brand Porsche, which could be one of the world’s largest…
By Rochdi Rais
Business April 16, 2021
Coinbase Global Inc. (NASDAQ: COIN) shares achieved a market valuation of $85.8 billion after its initial public offering (IPO) on…
By Rochdi Rais
Business March 5, 2021
Coinbase, the popular cryptocurrency exchange platform, is expecting a direct listing soon. The company said it has 43 million verified…
By Rochdi Rais